Dian Hong Pharmaceutical Group, Kangwang ® compound ketoconazole hair lotion, in 2015, was classified as a subsidiary of Bayer Group, a famous trademark in Yunnan Province, and an OTC drug anti-dandruff brand dedicated to the research of professional drug dandruff lotion
Dian Hong Pharmaceutical Group, formerly known as Kunming Dian Hong Pharmaceutical Co., Ltd., a Sino-US joint venture, was established in 1997 by Dian Hong Natural Medicine Factory and Dadong Enterprise of the United States, inheriting all the business of Dian Hong Natural Medicine Factory registered in 1993, and has always been controlled by the Chinese party since its establishment. In 2012, Kunming Dianhong Pharmaceutical Co., Ltd. was restructured and changed to Dianhong Pharmaceutical Group Co., Ltd.
Dianhong Pharmaceutical Group is a modern pharmaceutical enterprise group that is R&D-oriented, integrating R&D, production and marketing. Dian Hong Pharmaceutical has more than 3,000 employees, and its marketing network covers the whole country, Southeast Asian countries and Africa. As the backbone of the development of the cloud pharmaceutical industry, Dianhong Pharmaceutical has the courage to innovate and actively explore, and has grown into a well-known enterprise in China's pharmaceutical industry.
Through continuous brand building, the owner brand "Kangwang" of Dianhong Pharmaceutical has been jointly recognized as "well-known protection" by the State Administration for Industry and Commerce and the Supreme People's Court for its wide reputation and influence, and has been listed as one of the "Top 500 Most Valuable Brands in Asia". The Group's products have won the favor of many patients with reliable quality and definite efficacy. Among them, "Kangwang Hair Lotion", which is known as "anti-dandruff expert", "Pikang Wang", which is known as "skin disease buster", and "Tangor Women's Health Decoction", a well-known gynecological product, are a number of well-known brand products at home and abroad.
With the continuous improvement of the company's social popularity and reputation, the company has formally established the "one body, two wings" consumer health industry development strategy rooted in the brand of "taking the consumer health industry as the main body and expanding the pharmaceutical and international markets as the two wings". Under the guidance of this strategy, Dian Hong Pharmaceutical actively promotes the process of responsible self-care and self-medicine in China, and promotes the establishment of the International Self-Care Day. At the same time, we will carry out industrial integration, build a standardized platform for traditional Chinese medicine, and concentrate superior resources to make the national brand stronger and bigger.
Dian Hong Pharmaceutical Co., Ltd. has been jointly recognized as a "National Enterprise Technology Center" by five national ministries and commissions, listed as a "Provincial Key Pharmaceutical Enterprise" by the People's Government of Yunnan Province, rated as an "Honest Tax Paying Enterprise" by the All-China Federation of Industry and Commerce and the State Administration of Taxation, and rated as an advanced enterprise of "Double Love and Double Evaluation" by the All-China Federation of Trade Unions and the All-China Federation of Industry and Commerce. It has won many commendations and awards from relevant national ministries and commissions, provincial and municipal governments at all levels, and has received visits from national and foreign leaders, provincial and municipal leaders for many times.
Relying on the advantages of high-quality products and the accumulation of good corporate culture, Dianhong Pharmaceutical Co., Ltd. has a strong momentum, expands its territory, and stands out from its peers in the field of big health industry with a good development trend. Adhering to the corporate philosophy of "people-oriented, hard work, and rejuvenating medicine with science and technology", and with the corporate pursuit of "paying attention to health and benefiting mankind", Dian Hong is willing to join hands with people from all walks of life to contribute to a better future of the pharmaceutical industry.
On November 3, 2014, Bayer AG completed the acquisition of all shares of Dianhong Pharmaceutical Group. Dianhong Pharmaceutical is a privately owned pharmaceutical company based in Kunming, Yunnan Province, China, which mainly produces dermatological over-the-counter (OTC) drugs and traditional Chinese herbal products for the treatment of various gynecological diseases. Bayer paid a purchase price of 3.6 billion yuan (about 460 million euros).
